Literature DB >> 7500319

Soluble tumor necrosis factor receptors and soluble interleukin-6 receptor in fetal and maternal sera, coelomic and amniotic fluids in normal and pre-eclamptic pregnancies.

S L Opsjøn1, D Novick, N C Wathen, A P Cope, D Wallach, D Aderka.   

Abstract

The aim of this study was (a) to measure soluble tumor necrosis factor receptors (sTNF-Rs) and soluble interleukin-6 receptor (sIL-6-R) in coelomic and amniotic fluids, cord and maternal sera in pregnancy and labor, (b) to examine whether the changes in concentrations of biologically active TNF and IL-6 are related to changes in their soluble receptors, and (c) to determine if levels of soluble receptors in pre-eclamptic disorders differ from normal pregnancies at delivery. Materials collected from 206 women during pregnancy and at delivery were analyzed for soluble receptors by enzyme-linked immunosorbent assay (ELISA). All receptors were present in higher concentrations in coelomic than in the corresponding amniotic fluid. Concentrations increased in amniotic fluid from first to second trimester. The level of sIL-6-R then remained unchanged to term, but there was a decrease in the sTNF-Rs which might account for the simultaneous appearance of bioactive TNF. Labor did not affect the concentration of any receptor in amniotic fluid. In maternal serum, sTNF-Rs increased with gestational age and labor in parallel with IL-6. The origin and physiological importance of these soluble receptors are still unknown. In pre-eclamptic disorders p55 sTNF-R was elevated in maternal serum before initiation of labor compared to normal pregnancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7500319     DOI: 10.1016/0165-0378(95)00940-m

Source DB:  PubMed          Journal:  J Reprod Immunol        ISSN: 0165-0378            Impact factor:   4.054


  5 in total

1.  Elevated maternal soluble Gp130 and IL-6 levels and reduced Gp130 and SOCS-3 expressions in women complicated with preeclampsia.

Authors:  Yuping Wang; David F Lewis; Yang Gu; Shuang Zhao; Lynn J Groome
Journal:  Hypertension       Date:  2010-12-20       Impact factor: 10.190

2.  Maternal plasma concentrations of the soluble tumor necrosis factor receptor 2 are increased prior to the diagnosis of preeclampsia.

Authors:  Baha Sibai; Roberto Romero; Mark A Klebanoff; Madeline Murguia Rice; Steve Caritis; Marshall D Lindheimer; J Peter Van Dorsten; Mark Landon; Menachem Miodovnik; Mitchell Dombrowski; Paul Meis
Journal:  Am J Obstet Gynecol       Date:  2009-06       Impact factor: 8.661

3.  Cytokine soluble receptors in perinatal and early neonatal life.

Authors:  Efthimia Protonotariou; Demetrios Rizos; Ariadne Malamitsi-Puchner; Evangelia Moira; Angeliki Sarandakou; Emmanuil Salamalekis
Journal:  Mediators Inflamm       Date:  2003-06       Impact factor: 4.711

4.  Soluble endoglin, transforming growth factor-Beta 1 and soluble tumor necrosis factor alpha receptors in different clinical manifestations of preeclampsia.

Authors:  Luiza O Perucci; Karina B Gomes; Letícia G Freitas; Lara C Godoi; Patrícia N Alpoim; Melina B Pinheiro; Aline S Miranda; Antônio L Teixeira; Luci M Dusse; Lirlândia P Sousa
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

5.  Characterization of Natural Killer Cells and Cytokines in Maternal Placenta and Fetus of Diabetic Mothers.

Authors:  Cristiane de Castro Pernet Hara; Eduardo Luzía França; Danny Laura Gomes Fagundes; Adriele Ataides de Queiroz; Marilza Vieira Cunha Rudge; Adenilda Cristina Honorio-França; Iracema de Mattos Paranhos Calderon
Journal:  J Immunol Res       Date:  2016-05-16       Impact factor: 4.818

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.